CLINICAL_TRIALS
ClinicalTrials.gov record update
Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Multicenter, Prospective, Phase II Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06550921
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:17.637114+00:00
- Published At
- 2024-08-13T00:00:00+00:00
- Record Updated At
- 2024-08-13
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Advanced Hepatocellular Carcinoma", "Oligometastasis", "Ablation", "Anti-PD1 Antibody", "Lenvatinib"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-08-13"- protocolSection.identificationModule.nctId
"NCT06550921"- protocolSection.identificationModule.officialTitle
"Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Multicenter, Prospective, Phase II Study"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.